Nano-curcumin in the decrease of proteinuria in white rats (Rattus norvegicus) with preeclampsia

Subandi, Aulia Ilma Sahara, Nurdiana
{"title":"Nano-curcumin in the decrease of proteinuria in white rats (Rattus norvegicus) with preeclampsia","authors":"Subandi, Aulia Ilma Sahara, Nurdiana","doi":"10.20473/mog.v32i12024.8-13","DOIUrl":null,"url":null,"abstract":"HIGHLIGHTS\n\nThe size of curcumin was modified to nano scale in order to enhance its bioavailability and facilitate its absorption in the body.\nAs a herbal medicine, nano-curcumin has the ability to reduce proteinuria and serve as a preventive measure against preeclampsia.\n\n \nABSTRACT\nObjective: Since preeclampsia is one of the most serious hypertensive disorders in pregnancy, as it occurs in 5-7% of all pregnancies, and causes around 70,000 maternal deaths and 500,000 fetal deaths worldwide each year, this study aimed to determine the effect of nano-curcumin on proteinuria in pregnant white rats (Rattus norvegicus) with preeclampsia.\nMaterials and Methods: In this study, 24 white rats (Rattus norvegicus) were randomly selected and divided into six groups. Inclusion criteria included healthy rats aged 8 weeks or older, with normal blood pressure and weight, while exclusion criteria included sick, deceased, or prematurely birthing rats, and those with high blood pressure. Treatment, administered over six days from gestational days 13-18, involved L-NAME and nano-curcumin injections. Groups included K- (no treatment) and K+, P1, P2, P3, and P4 (treated with L-NAME and varying nano-curcumin doses). Blood pressure and proteinuria were evaluated on gestation days 12, 15, and 19 to confirm the preeclampsia model and assess nano-curcumin's effect on proteinuria. Urine collected over 24 hours in metabolic cages preceded rat termination. Data analysis utilized IBM SPSS version 23, including the Shapiro-Wilk test, parametric independent sample t-tests, One-Way ANOVA tests, and LSD post-hoc tests to identify group differences.  \nResults: The results of this study showed that nano-curcumin had the effect of reducing proteinuria in white rats with preeclampsia. The significant results of the One-Way Anova test was p=0.001 <0.05 and the LSD post-hoc test revealed that an effective dose was 25 mg/ml. It was found that higher nano-curcumin dose had a higher average of proteinuria.\nConclusion: Nano-curcumin can affect proteinuria in preeclampsia. The most effective dose is 25 mg/ml.","PeriodicalId":512701,"journal":{"name":"Majalah Obstetri &amp; Ginekologi","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Majalah Obstetri &amp; Ginekologi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/mog.v32i12024.8-13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

HIGHLIGHTS The size of curcumin was modified to nano scale in order to enhance its bioavailability and facilitate its absorption in the body. As a herbal medicine, nano-curcumin has the ability to reduce proteinuria and serve as a preventive measure against preeclampsia.   ABSTRACT Objective: Since preeclampsia is one of the most serious hypertensive disorders in pregnancy, as it occurs in 5-7% of all pregnancies, and causes around 70,000 maternal deaths and 500,000 fetal deaths worldwide each year, this study aimed to determine the effect of nano-curcumin on proteinuria in pregnant white rats (Rattus norvegicus) with preeclampsia. Materials and Methods: In this study, 24 white rats (Rattus norvegicus) were randomly selected and divided into six groups. Inclusion criteria included healthy rats aged 8 weeks or older, with normal blood pressure and weight, while exclusion criteria included sick, deceased, or prematurely birthing rats, and those with high blood pressure. Treatment, administered over six days from gestational days 13-18, involved L-NAME and nano-curcumin injections. Groups included K- (no treatment) and K+, P1, P2, P3, and P4 (treated with L-NAME and varying nano-curcumin doses). Blood pressure and proteinuria were evaluated on gestation days 12, 15, and 19 to confirm the preeclampsia model and assess nano-curcumin's effect on proteinuria. Urine collected over 24 hours in metabolic cages preceded rat termination. Data analysis utilized IBM SPSS version 23, including the Shapiro-Wilk test, parametric independent sample t-tests, One-Way ANOVA tests, and LSD post-hoc tests to identify group differences.   Results: The results of this study showed that nano-curcumin had the effect of reducing proteinuria in white rats with preeclampsia. The significant results of the One-Way Anova test was p=0.001 <0.05 and the LSD post-hoc test revealed that an effective dose was 25 mg/ml. It was found that higher nano-curcumin dose had a higher average of proteinuria. Conclusion: Nano-curcumin can affect proteinuria in preeclampsia. The most effective dose is 25 mg/ml.
纳米姜黄素在减少子痫前期白鼠蛋白尿中的作用
作为一种中药,纳米姜黄素具有降低蛋白尿和预防子痫前期的作用。摘要目的:由于子痫前期是妊娠期最严重的高血压疾病之一,发生率占妊娠总数的5%-7%,每年导致全球约7万名孕产妇死亡和50万名胎儿死亡,本研究旨在确定纳米姜黄素对子痫前期妊娠白鼠蛋白尿的影响:本研究随机选取 24 只白鼠(Rattus norvegicus),将其分为 6 组。纳入标准包括年龄在 8 周或以上、血压和体重正常的健康大鼠,排除标准包括患病、死亡或早产大鼠以及高血压大鼠。从妊娠第 13-18 天开始,对大鼠进行为期六天的治疗,包括注射 L-NAME 和纳米姜黄素。各组包括 K-(无治疗)和 K+、P1、P2、P3 和 P4(用 L-NAME 和不同剂量的纳米姜黄素治疗)。在妊娠第 12、15 和 19 天对血压和蛋白尿进行评估,以确认子痫前期模型并评估纳米姜黄素对蛋白尿的影响。在大鼠终止妊娠之前,在代谢笼中收集 24 小时的尿液。数据分析采用 IBM SPSS 版本 23,包括 Shapiro-Wilk 检验、参数独立样本 t 检验、单向方差分析检验和 LSD 事后检验,以确定组间差异。 结果研究结果表明,纳米姜黄素具有降低子痫前期白鼠蛋白尿的作用。单向Anova检验的显着性结果为P=0.001 <0.05,LSD事后检验显示有效剂量为25毫克/毫升。研究发现,纳米姜黄素剂量越高,蛋白尿的平均值越高:结论:纳米姜黄素能影响子痫前期患者的蛋白尿。最有效的剂量为 25 毫克/毫升。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信